Market Research Logo

Europe Amyotrophic Lateral Sclerosis Market and Competitive Landscape – 2017

Europe Amyotrophic Lateral Sclerosis Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Amyotrophic Lateral Sclerosis Market and Competitive Landscape – 2017, provides comprehensive insights into Amyotrophic Lateral Sclerosis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Amyotrophic Lateral Sclerosis market size and drug sales. This research also provides insights into Amyotrophic Lateral Sclerosis epidemiology and late stage pipeline.
The report is classified into nine sections – Amyotrophic Lateral Sclerosis overview with definitions, symptoms, etiology, diagnosis, treatment options; Amyotrophic Lateral Sclerosis pipeline insights covering late stage clinical trials pipeline; Amyotrophic Lateral Sclerosis prevalence trends by countries; Amyotrophic Lateral Sclerosis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Amyotrophic Lateral Sclerosis pipeline: Find out the drugs in clinical trials for Amyotrophic Lateral Sclerosis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Amyotrophic Lateral Sclerosis epidemiology: Find out the prevalence of Amyotrophic Lateral Sclerosis by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Amyotrophic Lateral Sclerosis products: Identify key products marketed and prescribed for Amyotrophic Lateral Sclerosis by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Amyotrophic Lateral Sclerosis market size: Find out the market size for Amyotrophic Lateral Sclerosis drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Amyotrophic Lateral Sclerosis drug sales: Find out the sales of Amyotrophic Lateral Sclerosis drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Amyotrophic Lateral Sclerosis drugs sales forecast: Sales forecast for Amyotrophic Lateral Sclerosis drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Amyotrophic Lateral Sclerosis market share analysis: Find out the market shares of Amyotrophic Lateral Sclerosis drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Amyotrophic Lateral Sclerosis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Amyotrophic Lateral Sclerosis market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Amyotrophic Lateral Sclerosis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Amyotrophic Lateral Sclerosis: Disease Overview
1.1. Amyotrophic Lateral Sclerosis Symptoms
1.2. Amyotrophic Lateral Sclerosis Etiology
1.3. Amyotrophic Lateral Sclerosis Diagnosis
1.4. Amyotrophic Lateral Sclerosis Treatment Options
2. Amyotrophic Lateral Sclerosis Pipeline Insights
2.1. Amyotrophic Lateral Sclerosis Phase 3 Clinical Trials
2.2. Amyotrophic Lateral Sclerosis Phase 2 Clinical Trials
2.3. Amyotrophic Lateral Sclerosis Phase 1 Clinical Trials
3. Amyotrophic Lateral Sclerosis Epidemiology Analysis
4. Germany Amyotrophic Lateral Sclerosis Market Insights
4.1. Marketed Products for Amyotrophic Lateral Sclerosis in Germany
4.2. Germany Amyotrophic Lateral Sclerosis Market Size & Forecast
4.3. Germany Amyotrophic Lateral Sclerosis Product Sales Forecast
4.4. Germany Amyotrophic Lateral Sclerosis Market Share Analysis
5. France Amyotrophic Lateral Sclerosis Market Insights
5.1. Marketed Products for Amyotrophic Lateral Sclerosis in France
5.2. France Amyotrophic Lateral Sclerosis Market Size & Forecast
5.3. France Amyotrophic Lateral Sclerosis Product Sales Forecast
5.4. France Amyotrophic Lateral Sclerosis Market Share Analysis
6. Italy Amyotrophic Lateral Sclerosis Market Insights
6.1. Marketed Products for Amyotrophic Lateral Sclerosis in Italy
6.2. Italy Amyotrophic Lateral Sclerosis Market Size & Forecast
6.3. Italy Amyotrophic Lateral Sclerosis Product Sales Forecast
6.4. Italy Amyotrophic Lateral Sclerosis Market Share Analysis
7. Spain Amyotrophic Lateral Sclerosis Market Insights
7.1. Marketed Products for Amyotrophic Lateral Sclerosis in Spain
7.2. Spain Amyotrophic Lateral Sclerosis Market Size & Forecast
7.3. Spain Amyotrophic Lateral Sclerosis Product Sales Forecast
7.4. Spain Amyotrophic Lateral Sclerosis Market Share Analysis
8. UK Amyotrophic Lateral Sclerosis Market Insights
8.1. Marketed Products for Amyotrophic Lateral Sclerosis in UK
8.2. UK Amyotrophic Lateral Sclerosis Market Size & Forecast
8.3. UK Amyotrophic Lateral Sclerosis Product Sales Forecast
8.4. UK Amyotrophic Lateral Sclerosis Market Share Analysis
9. Europe Amyotrophic Lateral Sclerosis Market Insights
9.1. Europe Amyotrophic Lateral Sclerosis Market Size & Forecast
9.2. Europe Amyotrophic Lateral Sclerosis Product Sales Forecast
9.3. Europe Amyotrophic Lateral Sclerosis Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Amyotrophic Lateral Sclerosis Phase 3 Clinical Trials, Global, 2017
Table 2: Amyotrophic Lateral Sclerosis Phase 2 Clinical Trials, Global, 2017
Table 3: Amyotrophic Lateral Sclerosis Phase 1 Clinical Trials, Global, 2017
Table 4: Amyotrophic Lateral Sclerosis Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Amyotrophic Lateral Sclerosis in Germany, 2017
Table 6: Germany Amyotrophic Lateral Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
Table 8: Germany Amyotrophic Lateral Sclerosis Market Trends, 2012 - 2021
Table 9: Marketed Products for Amyotrophic Lateral Sclerosis in France, 2017
Table 10: France Amyotrophic Lateral Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
Table 12: France Amyotrophic Lateral Sclerosis Market Trends, 2012 - 2021
Table 13: Marketed Products for Amyotrophic Lateral Sclerosis in Italy, 2017
Table 14: Italy Amyotrophic Lateral Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
Table 16: Italy Amyotrophic Lateral Sclerosis Market Trends, 2012 - 2021
Table 17: Marketed Products for Amyotrophic Lateral Sclerosis in Spain, 2017
Table 18: Spain Amyotrophic Lateral Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
Table 20: Spain Amyotrophic Lateral Sclerosis Market Trends, 2012 - 2021
Table 21: Marketed Products for Amyotrophic Lateral Sclerosis in UK, 2017
Table 22: UK Amyotrophic Lateral Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
Table 24: UK Amyotrophic Lateral Sclerosis Market Trends, 2012 - 2021
Table 25: Europe Amyotrophic Lateral Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Amyotrophic Lateral Sclerosis Pipeline by Phase (%), Global, 2017
Figure 2: Amyotrophic Lateral Sclerosis Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Amyotrophic Lateral Sclerosis Market Size ($mn), 2012 - 2021
Figure 4: Germany Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
Figure 5: Germany Amyotrophic Lateral Sclerosis Market Share by Products (%), 2016
Figure 6: Germany Amyotrophic Lateral Sclerosis Market - Future Market Share (%), 2021
Figure 7: France Amyotrophic Lateral Sclerosis Market Size ($mn), 2012 - 2021
Figure 8: France Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
Figure 9: France Amyotrophic Lateral Sclerosis Market Share by Products (%), 2016
Figure 10: France Amyotrophic Lateral Sclerosis Market - Future Market Share (%), 2021
Figure 11: Italy Amyotrophic Lateral Sclerosis Market Size ($mn), 2012 - 2021
Figure 12: Italy Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
Figure 13: Italy Amyotrophic Lateral Sclerosis Market Share by Products (%), 2016
Figure 14: Italy Amyotrophic Lateral Sclerosis Market - Future Market Share (%), 2021
Figure 15: Spain Amyotrophic Lateral Sclerosis Market Size ($mn), 2012 - 2021
Figure 16: Spain Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
Figure 17: Spain Amyotrophic Lateral Sclerosis Market Share by Products (%), 2016
Figure 18: Spain Amyotrophic Lateral Sclerosis Market - Future Market Share (%), 2021
Figure 19: UK Amyotrophic Lateral Sclerosis Market Size ($mn), 2012 - 2021
Figure 20: UK Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
Figure 21: UK Amyotrophic Lateral Sclerosis Market Share by Products (%), 2016
Figure 22: UK Amyotrophic Lateral Sclerosis Market - Future Market Share (%), 2021
Figure 23: Europe Amyotrophic Lateral Sclerosis Market Size ($mn), 2012 - 2021
Figure 24: Europe Amyotrophic Lateral Sclerosis Product Sales ($mn), 2012 - 2021
Figure 25: Europe Amyotrophic Lateral Sclerosis Market Share by Products (%), 2016
Figure 26: Europe Amyotrophic Lateral Sclerosis Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report